Kane Biotech, Inc. (KNE.V)
0.025
0.00 (0.00%)
CAD |
TSXV |
Oct 13, 16:00
Kane Biotech Net Income (Quarterly) : -0.8336M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.8336M |
| March 31, 2026 | -0.7148M |
| September 30, 2025 | -0.6073M |
| June 30, 2025 | -0.3485M |
| March 31, 2025 | -1.218M |
| December 31, 2024 | 0.2273M |
| September 30, 2024 | -0.6786M |
| June 30, 2024 | -1.216M |
| March 31, 2024 | -1.494M |
| September 30, 2023 | -1.244M |
| June 30, 2023 | -0.6819M |
| March 31, 2023 | -1.114M |
| December 31, 2022 | -0.8382M |
| September 30, 2022 | -1.039M |
| June 30, 2022 | -0.7946M |
| March 31, 2022 | -1.152M |
| December 31, 2021 | -1.257M |
| September 30, 2021 | -1.583M |
| June 30, 2021 | -0.9989M |
| March 31, 2021 | -1.011M |
| December 31, 2020 | -0.9458M |
| September 30, 2020 | -1.031M |
| June 30, 2020 | -0.5054M |
| March 31, 2020 | -1.364M |
| December 31, 2019 | -1.157M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.8216M |
| June 30, 2019 | 1.676M |
| March 31, 2019 | -0.6574M |
| December 31, 2018 | -0.6728M |
| September 30, 2018 | -0.9799M |
| June 30, 2018 | -0.6849M |
| March 31, 2018 | -0.873M |
| December 31, 2017 | -0.8887M |
| September 30, 2017 | -0.8692M |
| June 30, 2017 | -0.7905M |
| March 31, 2017 | -0.2377M |
| December 31, 2016 | -0.5001M |
| September 30, 2016 | -0.6161M |
| June 30, 2016 | -0.8513M |
| March 31, 2016 | -0.5814M |
| December 31, 2015 | -0.4781M |
| September 30, 2015 | -0.4118M |
| June 30, 2015 | -0.3329M |
| March 31, 2015 | -0.4871M |
| December 31, 2014 | -0.4553M |
| September 30, 2014 | -0.342M |
| June 30, 2014 | -0.5112M |
| March 31, 2014 | -0.3064M |
| December 31, 2013 | -0.1261M |
| September 30, 2013 | -0.3308M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Quest PharmaTech, Inc. | 3.401M |
| BriaCell Therapeutics Corp. | -9.920M |
| Vaxil Bio Ltd. | -0.064M |
| Waverley Pharma, Inc. | -0.1437M |
| Goldcoast Resource Corp. | -0.0999M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0081M |
| Total Expenses (Quarterly) | 0.8418M |
| EPS Diluted (Quarterly) | -0.0041 |
| Enterprise Value | 6.235M |
| Gross Profit Margin (Quarterly) | -143.2% |
| Profit Margin (Quarterly) | -10.29K% |
| Earnings Yield | -54.80% |
| Normalized Earnings Yield | -55.20 |